Inactive Instrument

Highlights VICS VANT

Equities

VCKA

KYG9440B1077

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Scilex Holding Company completed the acquisition of Vickers Vantage Corp. I from Vickers Venture Fund VI L.P. and Vickers Venture Fund VI Pte Ltd, managed by Vickers Venture Partners, Shaolin Capital Management LLC, Hudson Bay Capital Management LP and others in a reverse merger transaction.	22-11-09	CI
Vickers Vantage Corp. I Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-04	CI
Vickers Vantage I : Merger Agreement - Form 8-K	22-10-31	PU
Vickers Vantage Corp. I Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
Sorrento Therapeutics Unit Scilex Plans to Acquire Ancora Medical	22-07-07	MT
Vickers Vantage Corp. I Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Vickers Vantage I Extends Time to Complete Business Combination by Three Months	22-04-11	MT
Sorrento Therapeutics Unit Scilex Enters Deal with B Riley Financial for $5 Billion Financing Facility	22-03-25	MT
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., enters into a Non-Binding Term Sheet for a $5 Billion Committed Equity Financing Facility to be Effective in Connection with the Closing of the Merger with Vickers Vantage Corp I	22-03-25	AQ
Vickers Vantage I : SCILEX HOLDING COMPANY, A MAJORITY-OWNED SUBSIDIARY OF SORRENTO THERAPEUTICS, INC., TO BECOME PUBLICLY TRADED THROUGH A MERGER WITH VICKERS VANTAGE CORP. I - Form 8-K	22-03-21	PU
Sorrento's Scilex Says Semdexa Reduces Pain in Late-Stage Sciatica Trial; Scilex to Merge with Blank Check Firm	22-03-18	MT
Scilex Holding Company, a Majority-Owned Subsidiary of Sorrento Therapeutics, Inc., to Become Publicly Traded Through a Merger With Vickers Vantage Corp. I	22-03-17	AQ
Vickers Vantage Corp. I Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-24	CI
Vickers Vantage Corp. I Extends Deadline to Complete SPAC Deal	22-01-07	MT
Scilex Holding Company, a Sorrento Therapeutics Inc. Subsidiary, and Vickers Vantage Corp I Enter into Letter of Intent for Proposed Business Combination	21-12-07	AQ
Sorrento Unit Scilex Plans Business Combination With Blank-Check Firm Vickers Vantage Corp I	21-12-06	MT
Scilex Holding Company, a Sorrento Therapeutics Inc. Subsidiary, and Vickers Vantage Corp I (NASDAQ: VCKA) (“SPAC”) Enter into Letter of Intent for Proposed Business Combination	21-12-06	AQ
Scilex Holding Company signed a letter of intent to acquire Vickers Vantage Corp. I from Vickers Venture Fund VI L.P. and Vickers Venture Fund VI Pte Ltd, managed by Vickers Venture Partners, Shaolin Capital Management LLC, Hudson Bay Capital Management LP and others in a reverse merger transaction for $1.5 billion.	21-12-05	CI
Vickers Vantage Corp. I Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Vickers Vantage Corp. I Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights VICS VANT

Equities

VCKA

KYG9440B1077

Highlights

Filters